Omega Therapeutics, Inc. Quarterly Marketable Securities, Current in USD from Q4 2021 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Omega Therapeutics, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2021 to Q4 2023.
  • Omega Therapeutics, Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $4.99M, a 90.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $4.99M -$49.1M -90.8% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 $7.53M -$64.2M -89.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $7.44M -$75.4M -91% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $32.2M -$62.9M -66.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $54.1M +$15.2M +39.2% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $71.7M Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $82.8M Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $95.1M Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $38.8M Dec 31, 2021 10-K 2023-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.